Skeletal Anomalies Associated With Floating-Harbo Syndrome
Published on: October 28, 2025
Skeletal Anomalies Associated With Floating-Harbo Syndrome
Article author photo

Dylan Samedov Oshnoei

Bachelor of Medicine, Bachelor of Surgery - MBBS, Medicine, Imperial College London

Article reviewer photo

Jennifer Isaac

Proofreader, BA in English Literature and Spanish, The University of Southampton

In 1974, a patient seen at the Harbor General Hospital (Torrance, California, U.S.A.) was found to share an undiagnosed and astonishingly unique set of symptoms with a patient seen just one year earlier, at the Floating Hospital (Boston, U.S.A.).1,2 These symptoms were recognised as belonging to a new disorder, which was named as Floating-Harbor Syndrome (FHS); this name, ofcourse, was derived from the hospitals at which the first two cases of the disorder were seen.3,4,5 Since then, FHS has proven itself to be an extremely rare genetic disorder with only about 100 (>100) cases ever having been reported.6,7

FHS is caused by a mutation in the SRCAP gene of our DNA.8,9 In simple terms, that just means that FHS is caused by a change to a certain section of the chemical code in our cells. This code (DNA) is, itself, an actual chemical which contains the information necessary for our cells to build various proteins. Different sections (or genes)  of DNA are responsible for coding for different proteins, and if these genes change, then the proteins, which they are responsible for, may be built incorrectly. Consequently, mutations can cause these altered proteins to fail to perform their usual roles in various body processes and/or structures. In FHS, this mutation is responsible for a number of symptoms, including delayed speech development, short height, and distinct facial features.10,11,12 To find out more regarding the skeletal abnormalities associated with FHS, please read on. 

Skeletal abnormalities 

There is are range of skeletal abnormalities which may be associated with FHS:4,5,7,13,14,15,16,17,18,19,20,21,22,23

Growth/General  

  • Short height
  • A short neck
  • A broad chest
  • Low birth weight
  • Low birth length 
  • Delayed bone age
  • Joint laxity/hypermobility
  • Hip dysplasia

Facial structure 

  • A triangular face
  • Deep-set eyes
  • A prominent nose with a broad tip
  • A small head
  • A bulging and narrow forehead 

Fingers and toes

  • Clinodactyly: an abnormally curved finger
  • Syndactyly: webbed toes or fingers
  • Brachydactyly: disproportionately short fingers or toes
  • Nail clubbing
  • Dystrophic toenail; discoloured, thickened or deformed toenail

Dental

  • Macrodontia; some teeth are growing more than they should
  • Microdontia: some teeth grow less than they should
  • Micrognathia; small lower jaw
  • Malocclusion: misaligned teeth
  • Oligodontia; absence of 6 or more teeth from birth

Other symptoms

Development

  • Cryptorchidism; undescended testicles
  • Hypospadias, where the opening of the urethra is located in the wrong part of the penis
  • Heavy periods
  • Hirsutism: excessive hair growth in areas of the body where it's usually minimal
  • Sparse hair

Facial features

  • Short philtrum (the vertical indentation in the middle area above the upper lip, which connects to the nose)
  • Wide columella (the bridge of tissue that separates the nostrils at the bottom of your nose)
  • Long eyelashes
  • Low set ears, rotated rearwards
  • Broad mouth, sometimes with downturned corners
  • Ear/skin tag
  • Cleft lip/palate
  • Incomplete folding of the ears
  • Thin (upper) lip(s) 

Wider health complications 

Neuropsychological Symptoms

Furthermore, there are a number of neurological issues which may affect someone with FHS:4,13,23,24

Speech

Behaviour

  • Attention deficits
  • Anxiety
  • Depressive symptoms
  • Loss of appetite
  • Tantrums
  • Impulsiveness

Others

  • Seizures
  • Impaired/delayed motor skills; this may also play a part in speech deficits
  • Visuospatial impairment
  • Visuoconstructive apraxia; difficulty in assembling objects, drawing, or copying designs
  • Mild deficits in cognitive skills
  • Impaired visual and verbal memory

Summary

Floating-Harbour Syndrome (FHS) is an exceptionally rare genetic disorder first identified in two patients in the early 1970s at Harbour General Hospital (Torrance, California, U.S.A.) and Floating Hospital (Boston, U.S.A.), from which the syndrome derives its name. FHS is caused by a mutation in the SRCAP gene, which leads to changes in the DNA responsible for coding essential proteins. This mutation results in a unique set of symptoms, including delayed speech development, short stature, and specific facial features such as a triangular face, deep-set eyes, and a prominent nose. Other physical characteristics may include a short neck, a broad chest, and dental anomalies like macrodontia and micrognathia. Additionally, individuals with FHS may experience neurological challenges, including attention deficits, anxiety, and mild cognitive impairments. So far, slightly more than 100 cases have been reported.

Frequently asked questions 

What is floating-harbour syndrome?

Floating-Harbour Syndrome (FHS) is a very rare genetic disorder first identified in the 1970s. It is caused by a mutation in the SRCAP gene, which affects the body's ability to produce certain essential proteins. This leads to a unique set of symptoms, including delayed speech development, short stature, and distinctive facial features.

How is floating-harbour syndrome inherited? 

Floating-Harbour Syndrome is usually caused by a new mutation in the SRCAP gene, which means it often occurs randomly and is not always inherited from a parent. However, in rare cases, it can be passed down from an affected parent to their child.

What are the key symptoms to look out for? 

Key symptoms of FHS include delayed speech development, short height, and specific facial features such as a triangular face, deep-set eyes, and a prominent nose. Other signs can include dental anomalies, attention deficits, and anxiety, as well as many others..

Can floating-harbour syndrome be cured?  

Currently, there is no cure for Floating-Harbour Syndrome. Treatment focuses on managing the symptoms and providing support to help individuals live a full life. This may include speech therapy, special education, and medical care for any associated health issues.

What is the life expectancy of someone with floating-harbour syndrome?**  

While FHS can present various challenges, most individuals with the syndrome have a normal life expectancy. However, the quality of life can be improved with appropriate medical care and support.

How can families support a child with floating-harbour syndrome? 

Families can support a child with FHS by working closely with healthcare professionals to address the child's specific needs. This may involve regular medical check-ups, speech therapy, and creating a supportive and understanding environment at home and school.

References

  1. Pelletier G, Feingold M. Case report 1. In: Bergsma D, editor. Syndrome identification. Vol. 1. White Plains, NY: National Foundation-March of Dimes; 1973. p. 8-9.
  2. Leisti J, Hollister DW, Rimoin DL. Case report 2. In: Bergsma D, editor. Syndrome identification. Vol. 2. White Plains, NY: National Foundation-March of Dimes; 1974. 305 p.
  3. Robinson PL, Shohat M, Winter RM, Conte WJ, Gordon-Nesbitt D, Feingold M, Laron Z, Rimoin DL. A unique association of short stature, dysmorphic features, and speech impairment (Floating-Harbor syndrome). The Journal of pediatrics. 1988 Oct 1;113(4):703-6.
  4. Singh A, Bhatia HP, Sood S, Sharma N, Mohan A. A novel finding of oligodontia and ankyloglossia in a 14‐year‐old with Floating‐Harbor syndrome. Special Care in Dentistry. 2017 Nov;37(6):318-21.
  5. Ercoskun P, Yuce-Kahraman C. Novel findings in floating-harbor syndrome and a mini-review of the literature. Molecular Syndromology. 2021 Mar 2;12(1):52-6.
  6. Bo H, Jiang L, Zheng J, Sun J. Floating-Harbor Syndrome treated with recombinant human growth hormone: a case report and literature review. Frontiers in Pediatrics. 2021 Nov 5;9:747353.
  7. Dobrzynski W, Stawinska-Dudek J, Moryto N, Lipka D, Mikulewicz M. Floating–Harbor Syndrome: A Systematic Literature Review and Case Report. Journal of Clinical Medicine. 2024 Jun 12;13(12):3435.
  8. Ko J, Pomerantz JH, Perry H, Shieh JT, Slavotinek AM, Oberoi S, Klein OD. Case report of floating-harbor syndrome with bilateral cleft lip. The Cleft Palate-Craniofacial Journal. 2020 Jan;57(1):132-6.
  9. Budisteanu M, Bögershausen N, Papuc SM, Moosa S, Thoenes M, Riga D, Arghir A, Wollnik B. Floating-Harbor syndrome: Presentation of the first Romanian patient with a mutation and review of the literature. Balkan Journal of Medical Genetics. 2018 Jun 1;21(1):83-6.
  10. Rots D, Chater-Diehl E, Dingemans AJ, Goodman SJ, Siu MT, Cytrynbaum C, Choufani S, Hoang N, Walker S, Awamleh Z, Charkow J. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature. The American Journal of Human Genetics. 2021 Jun 3;108(6):1053-68.
  11. Allen DZ, Roy S. Otologic manifestations of Floating Harbor Syndrome (FHS): A case series and a review of the literature. Otolaryngology Case Reports. 2022 Jun 1;23:100406.
  12. Turkunova ME, Barbitoff YA, Serebryakova EA, Polev DE, Berseneva OS, Bashnina EB, Baranov VS, Glotov OS, Glotov AS. Molecular genetics and pathogenesis of the floating harbor syndrome: case report of long-term growth hormone treatment and a literature review. Frontiers in genetics. 2022 May 18;13:846101.
  13. Pouliquen D, Goldenberg A, Hannequin D, Lecointre C, Lechevallier J, Cormier-Daire V, Martinaud O. Detailed neuropsychological evaluation in a patient with Floating Harbor syndrome. Journal of Clinical and Experimental Neuropsychology. 2012 Jun 1;34(5):445-52.
  14. Bastaki L, El Nabi MM, Azab AS, Gouda SA, Al Wadaani AM, Naguib KK. Floating-Harbor syndrome in a Kuwaiti patient: a case report and literature review. EMHJ-Eastern Mediterranean Health Journal, 13 (4), 975-979, 2007. 2007.
  15. Penaloza JM, Garcia-Cruz D, Dávalos IP, Davalos NO, Garcia-Cruz MO, Pérez-Rulfo D, Sánchez-Corona J. A variant example of familial Floating-Harbor syndrome?. Genetic Counseling (Geneva, Switzerland). 2003 Jan 1;14(1):31-7.
  16. Genc G, Sarac A, Erkek Atay N, Kulali F. Floating-Harbor syndrome: case report. Minerva Pediatr. 2008 Apr;60(2):249-51. PMID: 18449141.
  17. Selimoğlu MA, Selimoğlu E, Ertekin V, Caner İ, Orbak Z. First Turkish patient with floating harbor syndrome with additional findings: Cryptorchidim and microcephaly. Yonsei Medical Journal. 2004 Apr;45(2):334-6.
  18. Houlston RS, Collins AL, Dennis NR, Temple IK. Further observations on the Floating-Harbor syndrome. Clinical dysmorphology. 1994 Apr 1;3(2):143-9.     
  19. Majewski F, Lenard HG. The floating-harbor syndrome. European journal of pediatrics. 1991 Feb;150:250-2.        
  20. White SM, Morgan A, Da Costa A, Lacombe D, Knight SJ, Houlston R, Whiteford ML, Newbury‐Ecob RA, Hurst JA. The phenotype of Floating–Harbor syndrome in 10 patients. American journal of medical genetics Part A. 2010 Apr;152(4):821-9.
  21. Lazebnik N, McPherson E, Rittmeyer LJ, Mulvihill JJ. The Floating Harbor syndrome with cardiac septal defect. American journal of medical genetics. 1996 Dec 18;66(3):300-2.
  22. Hersh JH, Groom KR, Yen FF, Verdi GD. Changing phenotype in Floating‐Harbor syndrome. American journal of medical genetics. 1998 Feb 26;76(1):58-61.
  23. Rosen, A.C., Newby, R.F., Sauer, C.M., Lacey, T., Hammeke, T.A. and Lubinsky, M.S., 1998. A further report on a case of Floating-Harbor Syndrome in a mother and daughter. Journal of clinical and experimental neuropsychology, 20(4), pp.483-495.
  24. Davalos IP, Figuera LE, Bobadilla L, Martinez-Martinez R, Matute E, Partida MG, Banuelos LA, Ramirez-Duenas ML. Floating-Harbor syndrome. A neuropsychological approach. Genetic Counseling (Geneva, Switzerland). 1996 Jan 1;7(4):283-8.
Share

Dylan Samedov Oshnoei

Bachelor of Medicine, Bachelor of Surgery - MBBS, Medicine, Imperial College London

As of September 2024, Dylan has been studying Medicine (MBBS 6YFT) at Imperial College London.
This comes after having achieved 3 A*s in Chemistry, Maths and Biology A-Levels.

During his A-Levels he also embarked upon a Level 3 EPQ which explored the extent to which homelessness affects psychiatric health. To help inform his presentation and dissertation, Dylan took surveys with fellow residents at a hostel. This process both developed his interest in research and enriched his appreciation of environmental health determinants. Consequently, he is keen to further investigate interdisciplinary and holistic approaches to healthcare as medical writer intern at Klarity.

On the other hand, his own diagnosis with Guillain-Barré Syndrome has cultivated a particular interest in neurology and immunology, leading him to write a number of articles focused on these areas at Klarity.

Furthermore, Dylan has worked as a cover supervisor in numerous high schools and a private tutor, roles which have sparked a passion for teaching; he is keen to continue adding to his expertise as a communicator of medical concepts here at Klarity to facilitate any future pursuits of academic teaching roles.

arrow-right